Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYNX: LYmph Node eXamination in Cat Allergen Immunotherapy
NCT07447869Phase 1Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of Allergenic Extract Standardized Cat Hair Acetone-Precipitated in cat allergy (2 cohorts), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Total number of analyzable cells from the lymph node fine-needle aspiration at Week 3. Started Apr 2026; status: recruiting.
02
Drugs
Allergenic Extract Standardized Cat Hair Acetone-Precipitated
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT07447869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07447869.